Why is the Australian Teletrial Program important?
Patients are at the heart of Australia’s most ambitious health equity program. On average, people living in rural and remote areas have shorter lives, higher levels of disease and injury, and poorer access to and use of health services.
The Australian Teletrial Program (ATP) wants the best standard of care treatment, the latest innovations, medicines, devices and preventative care to be accessible to everyone, wherever they live.
Teletrials explained
How teletrials are being used in the Northern Territory
Cardiologist Dr Angus Baumann is passionate about equity of health access, and here in the video below, he explains how teletrials is helping to improve remote patient access to clinical trials.
Facilitated by Prof Nik Zeps and hosted by ATP Director Kaye Hewson.

What is a teletrial?
Teletrial is a new, proven model for conducting clinical trials by connecting regional, rural and remote clinical trial sites to a primary site. The primary site supports local sites in building capacity and capability, promoting equitable health access and may lead to local sites becoming primary sites in the future. Teletrials involve numerous medical staff and researchers from various hospitals and health services in different locations. They use digital telecommunication to work as one team and conduct clinical trials closer to where patients live.
Get in touch
The Australian Teletrial Program (ATP) will improve access to, and participation in, clinical trials for rural, regional and remote Australians.
To receive ATP updates, sign up to our newsletter!